Pulmonology Medical News about Lung Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke
Lung Cancer, 10/07/09

Waller LL et al. – Determining the best strategy for overcoming erlotinib resistance may require understanding both pharmacokinetic and tumor–specific resistance mechanisms. Individually, the selection and dosing of erlotinib for the treatment of lung cancer patients who continue to smoke is a clinical challenge.

<< Previous
High prevalence of undiagnosed airflow limitation in patients...

Next >>
Pulmonary Nodulosis and Aseptic Granulomatous Lung Disease...

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09 Relevance Score: 68%

Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
Annals of Thoracic Surgery, 10/23/09 Relevance Score: 67%

The Association between Polymorphisms of XPD and Susceptibility of Lung Cancer: A meta Analysis
Chinese Journal of Lung Cancer, 10/21/09 Relevance Score: 67%

hsa-miR-125a-5p Enhances Invasion in Non-small Cell Lung Carcinoma Cell Lines by Upregulating Rock-1
Chinese Journal of Lung Cancer, 10/20/09 Relevance Score: 67%

CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
Lung Cancer, 10/06/09 Relevance Score: 67%